Hamidreza Motasadizadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hamidreza Motasadizadeh has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Samane Maghsoudian
Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
6 shared publicationsAlireza Shaabani
Department of Polymer and Materials Chemistry, Faculty of Chemistry and Petroleum Sciences, Shahid Beheshti University, Tehran, Iran
4 shared publications- Yousef Fatahi
Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications Nastaran Sayyari
School of Medicine, Qom University of Medical Sciences, Qom, Iran
3 shared publications- Rassoul Dinarvand
Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications Amir Rakhshani
Department of pharmaceutical nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- 9 August 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- p. 146646
Corrigendum to “Smart multilayer chitosan-based nanofibers for burn wounds: pH-responsive dual release of diclofenac sodium & Hamamelis virginiana extract: From design to in vitro & in vivo evaluation” [Int. J. Biol. Macromol. volume 320 (2025) article no. 145826]
- 9 August 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- p. 146646
Corrigendum to “Smart multilayer chitosan-based nanofibers for burn wounds: pH-responsive dual release of diclofenac sodium & Hamamelis virginiana extract: From design to in vitro & in vivo evaluation” [Int. J. Biol. Macromol. volume 320 (2025) article no. 145826]
- 17 July 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (18) , 5017-5039
Effect of nanomicelle morphology on peptide activity and ROS generation for enhancing chemotherapy efficacy in breast cancer
In cancer research, targeting specific molecular markers that are overexpressed on the tumor cell membrane has opened up opportunities for drug delivery. Yet, current technologies face challenges in achieving effective targeting. To enhance the targeting efficiency of peptides, researchers have explored different parameters, including the size and shape of nanoparticles, as well as the engineering of peptides. This study focuses on exploring the impact of nanoparticle shape on their uptake by cells and the efficiency of peptides in targeting specific receptors. We synthesized rod-shaped polymeric micelles (AuR-PM) using biodegradable copolymers consisting of zwitterionic methacryloyloxyethyl phosphorylcholine and polycaprolactone, enclosing gold nanoparticles (AuNPs) as the core. They were compared with previously synthesized spherical nanoparticles (AuS-PM) regarding cellular uptake under in vitro and in vivo conditions. The synergistic effect of PMs in combination with sonodynamic therapy was analyzed. Our findings clearly show that AuR-PM achieve a 1.495 ± 0.31 fold increase in intracellular accumulation compared to AuS-PM in static cultures. Additionally, targeted AuR-PM experienced a significant 1.625 ± 0.131 fold boost in cellular uptake over their non-targeted equivalents, representing a 1.307 ± 0.057 fold increase relative to the same comparison with AuS-PM. Based on the results obtained from confocal laser scanning microscopy and flow cytometry, the AuR-PM demonstrated approximately 3.25 ± 0.37 fold higher ROS production compared to AuS-PM in the MDA-MB231 cell line. AuR-PM exhibited improved effects in vivo, which can be attributed to their longer circulation time and greater tumor penetration. Histopathological analyses of essential tissues in mice carrying 4T1 tumors revealed minimal tissue damage following administration of DOX-loaded AuR-PM. These results highlight the importance of nanoparticle geometry in modulating cellular interactions and enhancing tumor targeting efficacy.
- 17 July 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (18) , 5017-5039
Effect of nanomicelle morphology on peptide activity and ROS generation for enhancing chemotherapy efficacy in breast cancer
In cancer research, targeting specific molecular markers that are overexpressed on the tumor cell membrane has opened up opportunities for drug delivery. Yet, current technologies face challenges in achieving effective targeting. To enhance the targeting efficiency of peptides, researchers have explored different parameters, including the size and shape of nanoparticles, as well as the engineering of peptides. This study focuses on exploring the impact of nanoparticle shape on their uptake by cells and the efficiency of peptides in targeting specific receptors. We synthesized rod-shaped polymeric micelles (AuR-PM) using biodegradable copolymers consisting of zwitterionic methacryloyloxyethyl phosphorylcholine and polycaprolactone, enclosing gold nanoparticles (AuNPs) as the core. They were compared with previously synthesized spherical nanoparticles (AuS-PM) regarding cellular uptake under in vitro and in vivo conditions. The synergistic effect of PMs in combination with sonodynamic therapy was analyzed. Our findings clearly show that AuR-PM achieve a 1.495 ± 0.31 fold increase in intracellular accumulation compared to AuS-PM in static cultures. Additionally, targeted AuR-PM experienced a significant 1.625 ± 0.131 fold boost in cellular uptake over their non-targeted equivalents, representing a 1.307 ± 0.057 fold increase relative to the same comparison with AuS-PM. Based on the results obtained from confocal laser scanning microscopy and flow cytometry, the AuR-PM demonstrated approximately 3.25 ± 0.37 fold higher ROS production compared to AuS-PM in the MDA-MB231 cell line. AuR-PM exhibited improved effects in vivo, which can be attributed to their longer circulation time and greater tumor penetration. Histopathological analyses of essential tissues in mice carrying 4T1 tumors revealed minimal tissue damage following administration of DOX-loaded AuR-PM. These results highlight the importance of nanoparticle geometry in modulating cellular interactions and enhancing tumor targeting efficacy.
- 18 February 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 305 (Pt 2) , 141191
Polyethylene oxide-chitosan-doxorubicin/polycaprolactone-chitosan-curcumin pH-sensitive core/shell nanofibrous mats for the treatment of breast cancer: Fabrication, characterization and in vitro and in vivo evaluation
- 18 February 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 305 (Pt 2) , 141191
Polyethylene oxide-chitosan-doxorubicin/polycaprolactone-chitosan-curcumin pH-sensitive core/shell nanofibrous mats for the treatment of breast cancer: Fabrication, characterization and in vitro and in vivo evaluation
- Open Access
Platelet Membrane-Coated SPION for Targeted Paclitaxel Delivery and Magnetic Hyperthermia in Cancer Therapy
Due to the limited therapeutic efficacy and side effects associated with conventional chemotherapy, researchers have turned their attention to developing targeted drug delivery systems using advanced nanotechnology. Coating nanoparticles (NPs) with cell membranes is a promising strategy because it extends their circulation times and allows them to selectively adhere to damaged vessel sites through the platelet membrane surface, thereby enhancing tumor uptake. Herein, we have developed a biomimetic drug delivery system consisting of superparamagnetic iron oxide nanoparticles (SPIONs) coated by platelet membranes (PM) for carrying Paclitaxel (PTX) to exploit the synergism effect of chemotherapy and magnetic hyperthermia. Controlled-release PTX nanoparticles exhibited consistent behavior over time, indicating no significant difference in release between SPION/PTX and SPION/PTX/PM at pH 7.4. However, at pH 5.5, improved release was observed, specifically a 1.4-fold increase for SPION/PTX/PM. The confocal and flow cytometry results show an enhancement in the cellular uptake of SPION/PTX/PM nanoparticles, with an average fluorescence intensity of 142 ±12.5. MTT results indicated that SPION/PTX/PM demonstrates superior cytotoxic effects compared to SPION/PTX and PTX alone, showing an IC50 value of 5 μg/mL after 48 h of treatment. Furthermore, the IC50 decreased to 1 μg/mL when an alternating magnetic field was applied. Hence, the in vivo results and histopathological staining showed that the SPION/PTX/PM-AFM treatment group exhibited the highest rate of tumor growth inhibition, reaching nearly 92.14 %. These findings highlight the potential of using platelet membrane-coated nanoparticles for targeted delivery, combining magnetic hyperthermia and chemotherapy to minimize chemotherapy’s undesirable effects while maximizing therapeutic outcomes.
Open AccessPlatelet Membrane-Coated SPION for Targeted Paclitaxel Delivery and Magnetic Hyperthermia in Cancer Therapy
Due to the limited therapeutic efficacy and side effects associated with conventional chemotherapy, researchers have turned their attention to developing targeted drug delivery systems using advanced nanotechnology. Coating nanoparticles (NPs) with cell membranes is a promising strategy because it extends their circulation times and allows them to selectively adhere to damaged vessel sites through the platelet membrane surface, thereby enhancing tumor uptake. Herein, we have developed a biomimetic drug delivery system consisting of superparamagnetic iron oxide nanoparticles (SPIONs) coated by platelet membranes (PM) for carrying Paclitaxel (PTX) to exploit the synergism effect of chemotherapy and magnetic hyperthermia. Controlled-release PTX nanoparticles exhibited consistent behavior over time, indicating no significant difference in release between SPION/PTX and SPION/PTX/PM at pH 7.4. However, at pH 5.5, improved release was observed, specifically a 1.4-fold increase for SPION/PTX/PM. The confocal and flow cytometry results show an enhancement in the cellular uptake of SPION/PTX/PM nanoparticles, with an average fluorescence intensity of 142 ±12.5. MTT results indicated that SPION/PTX/PM demonstrates superior cytotoxic effects compared to SPION/PTX and PTX alone, showing an IC50 value of 5 μg/mL after 48 h of treatment. Furthermore, the IC50 decreased to 1 μg/mL when an alternating magnetic field was applied. Hence, the in vivo results and histopathological staining showed that the SPION/PTX/PM-AFM treatment group exhibited the highest rate of tumor growth inhibition, reaching nearly 92.14 %. These findings highlight the potential of using platelet membrane-coated nanoparticles for targeted delivery, combining magnetic hyperthermia and chemotherapy to minimize chemotherapy’s undesirable effects while maximizing therapeutic outcomes.